Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cost effectiveness of enoxaparin in acute ST-segment elevation myocardial infarction: the ExTRACT-TIMI 25 (Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction 25) study.
Marcoff L, Zhang Z, Zhang W, Ewen E, Jurkovitz C, Leguet P, Kolm P, Weintraub WS. Marcoff L, et al. Among authors: kolm p. J Am Coll Cardiol. 2009 Sep 29;54(14):1271-9. doi: 10.1016/j.jacc.2009.05.060. J Am Coll Cardiol. 2009. PMID: 19778669 Free article. Clinical Trial.
Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients.
Weintraub WS, Boden WE, Zhang Z, Kolm P, Zhang Z, Spertus JA, Hartigan P, Veledar E, Jurkovitz C, Bowen J, Maron DJ, O'Rourke R, Dada M, Teo KK, Goeree R, Barnett PG; Department of Veterans Affairs Cooperative Studies Program No. 424 (COURAGE Trial) Investigators and Study Coordinators. Weintraub WS, et al. Among authors: kolm p. Circ Cardiovasc Qual Outcomes. 2008 Sep;1(1):12-20. doi: 10.1161/CIRCOUTCOMES.108.798462. Circ Cardiovasc Qual Outcomes. 2008. PMID: 20031783 Clinical Trial.
Cost-effectiveness of revascularization strategies: the ASCERT study.
Zhang Z, Kolm P, Grau-Sepulveda MV, Ponirakis A, O'Brien SM, Klein LW, Shaw RE, McKay C, Shahian DM, Grover FL, Mayer JE, Garratt KN, Hlatky M, Edwards FH, Weintraub WS. Zhang Z, et al. Among authors: kolm p. J Am Coll Cardiol. 2015 Jan 6;65(1):1-11. doi: 10.1016/j.jacc.2014.09.078. J Am Coll Cardiol. 2015. PMID: 25572503 Free PMC article.
Cost in the use of enoxaparin compared with unfractionated heparin in patients with atrial fibrillation undergoing a transesophageal echocardiography-guided cardioversion (from Assessment of Cardioversion using Transesophageal Echocardiography [ACUTE] II randomized multicenter study).
Zhao L, Zhang Z, Kolm P, Jasper S, Lewis C, Klein A, Weintraub W; ACUTE II Investigators. Zhao L, et al. Among authors: kolm p. Am J Cardiol. 2008 Feb 1;101(3):338-42. doi: 10.1016/j.amjcard.2007.09.075. Am J Cardiol. 2008. PMID: 18237596 Clinical Trial.
Long-term cost-effectiveness of clopidogrel in STEMI patients.
Zhang Z, Kolm P, Mosse F, Jackson J, Zhao L, Weintraub WS. Zhang Z, et al. Among authors: kolm p. Int J Cardiol. 2009 Jul 10;135(3):353-60. doi: 10.1016/j.ijcard.2008.04.011. Epub 2008 Jun 30. Int J Cardiol. 2009. PMID: 18586338 Clinical Trial.
Cost-effectiveness of enoxaparin compared with unfractionated heparin in ST elevation myocardial infarction patients undergoing pharmacological reperfusion: a Canadian analysis of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment - Thrombolysis in Myocardial Infarction (ExTRACT-TIMI) 25 trial.
Welsh RC, Sauriol L, Zhang Z, Kolm P, Weintraub WS, Theroux P. Welsh RC, et al. Among authors: kolm p. Can J Cardiol. 2009 Dec;25(12):e399-405. doi: 10.1016/s0828-282x(09)70532-x. Can J Cardiol. 2009. PMID: 19960133 Free PMC article. Clinical Trial.
195 results